Medpace Holdings [MEDP] vs Danaher [DHR] Detailed Stock Comparison

Medpace Holdings Inc.

NASDAQ
Loading...

Danaher Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Medpace Holdings Inc. wins in 11 metrics, Danaher Corporation wins in 9 metrics, with 0 ties. Medpace Holdings Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Medpace Holdings Inc. Danaher Corporation Better
P/E Ratio (TTM) 26.90 34.61 Medpace Holdings Inc.
Price-to-Book Ratio 25.37 2.40 Danaher Corporation
Debt-to-Equity Ratio 20.43 37.17 Medpace Holdings Inc.
PEG Ratio 1.75 3.84 Medpace Holdings Inc.
EV/EBITDA 18.94 17.69 Danaher Corporation
Profit Margin (TTM) 17.19% 14.89% Medpace Holdings Inc.
Operating Margin (TTM) 20.03% 22.94% Danaher Corporation
EBITDA Margin (TTM) 20.03% 22.94% Danaher Corporation
Return on Equity 77.25% 7.08% Medpace Holdings Inc.
Return on Assets (TTM) 17.47% 4.19% Medpace Holdings Inc.
Free Cash Flow (TTM) $681.87M $5.26B Danaher Corporation
Dividend Yield N/A 0.56% N/A
1-Year Return 56.69% -10.25% Medpace Holdings Inc.
Price-to-Sales Ratio (TTM) 4.38 5.10 Medpace Holdings Inc.
Enterprise Value $11.19B $140.38B Danaher Corporation
EV/Revenue Ratio 4.18 5.67 Medpace Holdings Inc.
Gross Profit Margin (TTM) 27.78% 60.34% Danaher Corporation
Revenue per Share (TTM) $94 $35 Medpace Holdings Inc.
Earnings per Share (Diluted) $15.26 $5.16 Medpace Holdings Inc.
Beta (Stock Volatility) 1.39 0.99 Danaher Corporation
Short % of Float 5.30% 1.10% Danaher Corporation

Medpace Holdings Inc. vs Danaher Corporation Stock Performance Analysis

Loading Price Chart...

MEDP
DHR

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Medpace Holdings Inc.0.03%2.10%12.58%3.06%-16.39%-18.13%
Danaher Corporation0.56%-1.32%11.85%-5.38%-20.75%-21.40%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Medpace Holdings Inc.56.69%110.68%163.23%1,566.69%1,566.69%1,566.69%
Danaher Corporation-10.25%-15.98%-20.94%174.08%416.93%738.84%

Performance & Financial Health Analysis: Medpace Holdings Inc. vs Danaher Corporation

MetricMEDPDHR
Market Information
Market Cap i$11.72B$126.39B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i574,9125,174,666
90 Day Avg. Volume i396,3544,357,215
Last Close$467.50$181.10
52 Week Range$294.07 - $628.92$160.93 - $242.80
% from 52W High-25.67%-25.41%
All-Time High$628.92 (Jan 16, 2026)$296.06 (Sep 06, 2021)
% from All-Time High-25.67%-38.83%
Growth Metrics
Quarterly Revenue Growth0.27%0.04%
Quarterly Earnings Growth0.08%0.08%
Financial Health
Profit Margin (TTM) i0.17%0.15%
Operating Margin (TTM) i0.20%0.23%
Return on Equity (TTM) i0.77%0.07%
Debt to Equity (MRQ) i20.4337.17
Cash & Liquidity
Book Value per Share (MRQ)$16.18$74.32
Cash per Share (MRQ)$22.85$8.06
Operating Cash Flow (TTM) i$739.17M$6.44B
Levered Free Cash Flow (TTM) i$514.58M$4.57B
Dividends
Last 12-Month Dividend Yield iN/A0.56%
Last 12-Month Dividend iN/A$1.28

Valuation & Enterprise Metrics Analysis: Medpace Holdings Inc. vs Danaher Corporation

MetricMEDP (Apr 26, 2026)DHR (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i26.9034.61
Forward P/E i21.9719.64
PEG Ratio i1.753.84
Price to Sales (TTM) i4.385.10
Price to Book (MRQ) i25.372.40
Market Capitalization
Market Capitalization i$11.72B$126.39B
Enterprise Value i$11.19B$140.38B
Enterprise Value Metrics
Enterprise to Revenue i4.185.67
Enterprise to EBITDA i18.9417.69
Risk & Other Metrics
Beta i1.390.99
Book Value per Share (MRQ) i$16.18$74.32

Financial Statements Comparison: Medpace Holdings Inc. vs Danaher Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMEDP (2025)DHR (2025)
Revenue/Sales i2.53B24.57B
Cost of Goods Sold i1.77B10.05B
COGS % of Revenue i69.9%40.9%
Gross Profit i760.62M14.52B
Gross Margin i30.1%59.1%
Research & Development iN/A1.60B
Operating Income (EBIT) i534.94M4.69B
Operating Margin i21.1%19.1%
EBITDA i570.79M7.17B
EBITDA Margin i22.6%29.2%
Pre-Tax Income i542.38M4.23B
Pre-Tax Income % of Revenue i21.4%17.2%
Income Tax i91.25M633.00M
Income Tax % of Revenue i3.6%2.6%
Net Income (Profit) i451.12M3.61B
Profit Margin i17.8%14.7%

Balance Sheet & Liquidity Metrics

MetricMEDP (2025)DHR (2025)
Cash & Equivalents i497.05M4.62B
Total Current Assets i989.62M12.76B
Total Current Assets % of Revenue i39.1%51.9%
Total Current Liabilities i1.34B6.81B
Total Current Liabilities % of Revenue i53.1%27.7%
Long-Term Debt i113.64M19.50B
Long-Term Debt % of Revenue i4.5%79.4%
Total Shareholders Equity i459.07M52.54B
Retained Earnings i-459.98M46.89B
Retained Earnings % of Revenue i-18.2%190.9%
Property, Plant & Equipment i171.17M2.14B

Cash Flow Statement Comparison

MetricMEDP (2025)DHR (2025)
Operating Cash Flow i643.24M5.64B
Operating Cash Flow % of Revenue i25.4%23.0%
Capital Expenditures i-31.36M-1.12B
Free Cash Flow i681.87M5.26B
FCF Margin i26.9%21.4%
Debt Repayment i0-500.00M
Common Stock Repurchase i-917.39M-3.09B

Short Interest & Institutional Ownership Analysis

MetricMEDPDHR
Shares Short i1.22M6.94M
Short Ratio i3.931.68
Short % of Float i5.30%1.10%
Shares Outstanding i28.56M707.70M
Float Shares i23.01M630.65M
% Held by Insiders i19.39%10.78%
% Held by Institutions i86.88%85.08%
% Held by Public i-6.27%4.14%

Dividend Analysis & Yield Comparison: Medpace Holdings Inc. vs Danaher Corporation

MetricMEDPDHR
Last 12-Month Dividend iN/A$1.28
Last 12-Month Dividend Yield iN/A0.56%
3-Year Avg Annual Dividend iN/A$10.51
3-Year Avg Dividend Yield iN/A1.11%
3-Year Total Dividends iN/A$31.54
Ex-Dividend DateN/ADec 26, 2025